End Cash: The amount of cash held by the company for the given period.
Oncternal Therapeutics, Inc. (ONCT) had End Cash of $6.70M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.79M |
|
$-39.48M |
|
-- |
|
$0.79M |
|
$42.50M |
|
$-41.71M |
|
$2.23M |
|
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-41.71M |
|
$-43.35M |
|
2.94M |
|
2.94M |
|
$-13.43 |
|
$-13.43 |
|
| Balance Sheet Financials | |
$36.06M |
|
-- |
|
$0.67M |
|
$36.73M |
|
$5.20M |
|
-- |
|
$1.48M |
|
$6.68M |
|
$30.05M |
|
$30.05M |
|
$30.05M |
|
2.95M |
|
| Cash Flow Statement Financials | |
$-32.16M |
|
$0.65M |
|
$1.07M |
|
$37.14M |
|
|
End Cash |
$6.70M |
$-30.45M |
|
$7.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5313.89% |
|
-5313.89% |
|
-5521.91% |
|
-5029.17% |
|
-5029.17% |
|
$-32.16M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-131.37% |
|
-131.37% |
|
-107.49% |
|
-131.37% |
|
$10.19 |
|
$-10.94 |
|
$-10.94 |
|